Search research articles
Contact Us
Filters
Showing results (441-450 of 521) with videos related to
Page
of 53
Sort By:
Contemporary Clinical Trials
|
March 27, 2017
Patient engagement and study design of PROP UP: A multi-site patient-centered prospective observational study of patients undergoing hepatitis C treatment
Donna M Evon, Carol E Golin, Paul Stewart, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 9, 2008
Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis C
David R Nelson, Vinod Rustgi, Vijayan Balan, et al.
The Plant Cell
|
September 23, 2015
Whole-Genome Resequencing Reveals Extensive Natural Variation in the Model Green Alga Chlamydomonas reinhardtii
Jonathan M Flowers, Khaled M Hazzouri, Gina M Pham, et al.
Journal of Clinical Gastroenterology
|
May 16, 2014
Sustained virologic response rates with telaprevir-based therapy in treatment-naive patients evaluated by race or ethnicity
Steven L Flamm, Andrew J Muir, Michael W Fried, et al.
Hepatology Communications
|
October 9, 2019
Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV-TARGET Analysis
Kavita Radhakrishnan, Adrian M Di Bisceglie, K Rajender Reddy, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 12, 2022
Pathogen-induced biosynthetic pathways encode defense-related molecules in bread wheat
Guy Polturak, Martin Dippe, Michael J Stephenson, et al.
Clinical and Experimental Gastroenterology
|
December 7, 2016
HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection
Christoph Sarrazin, Francesco Castelli, Pietro Andreone, et al.
Annals of Hepatology
|
December 15, 2011
Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients
David R Nelson, Stefan Zeuzem, Pietro Andreone, et al.
Antiviral Therapy
|
March 8, 2006
A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy
Vijayan Balan, David R Nelson, Mark S Sulkowski, et al.
Genome Biology and Evolution
|
April 4, 2025
Chromosome-Level Assemblies of the Allohexaploid Genomes of Conyza sumatrensis and Conyza bonariensis
Anthony Côrtes Gomes, Jacob Montgomery, André Lucas Simões Araujo, et al.
Page
of 53
Search research articles
Search
Showing results (441-450 of 521) with videos related to
Sort By:
Page
of 53
Contemporary Clinical Trials
|
March 27, 2017
Patient engagement and study design of PROP UP: A multi-site patient-centered prospective observational study of patients undergoing hepatitis C treatment
Donna M Evon, Carol E Golin, Paul Stewart, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 9, 2008
Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis C
David R Nelson, Vinod Rustgi, Vijayan Balan, et al.
The Plant Cell
|
September 23, 2015
Whole-Genome Resequencing Reveals Extensive Natural Variation in the Model Green Alga Chlamydomonas reinhardtii
Jonathan M Flowers, Khaled M Hazzouri, Gina M Pham, et al.
Journal of Clinical Gastroenterology
|
May 16, 2014
Sustained virologic response rates with telaprevir-based therapy in treatment-naive patients evaluated by race or ethnicity
Steven L Flamm, Andrew J Muir, Michael W Fried, et al.
Hepatology Communications
|
October 9, 2019
Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV-TARGET Analysis
Kavita Radhakrishnan, Adrian M Di Bisceglie, K Rajender Reddy, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 12, 2022
Pathogen-induced biosynthetic pathways encode defense-related molecules in bread wheat
Guy Polturak, Martin Dippe, Michael J Stephenson, et al.
Clinical and Experimental Gastroenterology
|
December 7, 2016
HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection
Christoph Sarrazin, Francesco Castelli, Pietro Andreone, et al.
Annals of Hepatology
|
December 15, 2011
Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients
David R Nelson, Stefan Zeuzem, Pietro Andreone, et al.
Antiviral Therapy
|
March 8, 2006
A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy
Vijayan Balan, David R Nelson, Mark S Sulkowski, et al.
Genome Biology and Evolution
|
April 4, 2025
Chromosome-Level Assemblies of the Allohexaploid Genomes of Conyza sumatrensis and Conyza bonariensis
Anthony Côrtes Gomes, Jacob Montgomery, André Lucas Simões Araujo, et al.
Page
of 53